Cargando…

A national case–control study investigating demographic and environmental factors associated with NMOSD

BACKGROUND: Risk factors for aquaporin-4 (AQP4+) antibody neuromyelitis optica spectrum disorder (NMOSD) are not well-established. OBJECTIVE: To investigate demographic and environmental factors associated with NMOSD using a validated questionnaire and case–control design. METHODS: We enrolled patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rotstein, Dalia L, Wolfson, Christina, Carruthers, Robert, Freedman, Mark S, Morrow, Sarah A, Lee, Liesly, Burton, Jodie M, Nisenbaum, Rosane, Konig, Andrea, Magalhaes, Sandra, Marrie, Ruth Ann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Original Research Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152218/ https://www.ncbi.nlm.nih.gov/pubmed/36803237 http://dx.doi.org/10.1177/13524585231151953

Ejemplares similares

Radiologically isolated syndrome and the possibility of preclinical disease activity in aquaporin-4 antibody NMOSD
por: Rotstein, Dalia L
Publicado: (2022)

Contemporary management challenges in seropositive NMOSD
por: Costello, Fiona, et al.
Publicado: (2022)

Chronic Cognitive Impairment in AQP4+ NMOSD With Improvement in Cognition on Eculizumab: A Report of Two Cases
por: Saab, Georges, et al.
Publicado: (2022)

Adverse Events in NMOSD Therapy
por: Giglhuber, Katrin, et al.
Publicado: (2022)

High prevalence of comorbidities at diagnosis in immigrants with multiple sclerosis
por: Rotstein, Dalia, et al.
Publicado: (2021)

Progress in treatment of neuromyelitis optica spectrum disorders (NMOSD): Novel insights into therapeutic possibilities in NMOSD
por: Shi, Mingchao, et al.
Publicado: (2022)

Health service utilization in immigrants with multiple sclerosis
por: Rotstein, Dalia L., et al.
Publicado: (2020)

COVID-19 in MS and NMOSD: A multicentric online national survey in Chile
por: Ciampi, Ethel, et al.
Publicado: (2020)

Comparative study of AQP4-NMOSD, MOGAD and seronegative NMOSD: a single-center Belgian cohort
por: Dauby, Solène, et al.
Publicado: (2021)

Lupus and NMOSD: The Blending of Humoral Autoimmunity
por: Ochi, Maria Goretti S., et al.
Publicado: (2020)

Epidemiology of Pediatric NMOSD in Germany and Austria
por: Lechner, Christian, et al.
Publicado: (2020)

Etiology, effects and management of comorbidities in multiple sclerosis: recent advances
por: Marrie, Ruth Ann, et al.
Publicado: (2023)

International Delphi Consensus on the Management of AQP4-IgG+ NMOSD: Recommendations for Eculizumab, Inebilizumab, and Satralizumab
por: Paul, Friedemann, et al.
Publicado: (2023)

Collaborative International Research in Clinical and Longitudinal Experience Study in NMOSD
por: Cook, Lawrence J., et al.
Publicado: (2019)

Plasmapheresis for NMOSD: Not a Rescue Therapy Anymore!?
por: Bhatia, Rohit, et al.
Publicado: (2019)

Plegia to walking: AHSCBMT in severe NMOSD relapse
por: Carlisle, Nicola, et al.
Publicado: (2020)

Therapy challenges for NMOSD in a patient with HIV
por: Engels, Daniel, et al.
Publicado: (2023)

The effect of smoking on MRI lesion resolution in NMOSD-AQP4 and MOGAD
por: Berhanu, David, et al.
Publicado: (2023)

Incidence of neuromyelitis optica spectrum disorder (NMOSD) in China: A national population-based study
por: Tian, De-Cai, et al.
Publicado: (2020)

NMOSD-like and longitudinal extensive HTLV1-associated myelitis are extremes that flank an overlooked continuum
por: Bonnan, Mickael, et al.
Publicado: (2021)

Pediatric NMOSD: A Review and Position Statement on Approach to Work-Up and Diagnosis
por: Tenembaum, Silvia, et al.
Publicado: (2020)

Plasma Complement 3 and Complement 4 Are Promising Biomarkers for Distinguishing NMOSD From MOGAD and Are Associated With the Blood-Brain-Barrier Disruption in NMOSD
por: Lin, Liuyu, et al.
Publicado: (2022)

AQP4-IgG NMOSD, MOGAD, and double-seronegative NMOSD: is it possible to depict the antibody subtype using magnetic resonance imaging?
por: Fragoso, Diego Cardoso, et al.
Publicado: (2023)

Corrigendum to ‘Incidence of neuromyelitis optica spectrum disorder (NMOSD) in China: A national population-based study’
por: Tian, De-Cai, et al.
Publicado: (2021)

High-throughput investigation of molecular and cellular biomarkers in NMOSD
por: Yandamuri, Soumya S., et al.
Publicado: (2020)

Blood pressure and body fat percent in women with NMOSD
por: Chen, Xiaohong, et al.
Publicado: (2019)

Cognitive impairment in NMOSD—More questions than answers
por: Czarnecka, Dominika, et al.
Publicado: (2020)

NMOSD—Diagnostic Dilemmas Leading towards Final Diagnosis
por: Szewczyk, Anna K., et al.
Publicado: (2022)

NMOSD and MOGAD Dual Positivity: An Extremely Rare Phenomenon
por: Agarwal, Ayush, et al.
Publicado: (2022)

Corrigendum: Pediatric NMOSD: A Review and Position Statement on Approach to Work-Up and Diagnosis
por: Tenembaum, Silvia, et al.
Publicado: (2021)

Differing trends in the incidence of vascular comorbidity in MS and the general population
por: Marrie, Ruth Ann, et al.
Publicado: (2016)

Autoantibody to MOG suggests two distinct clinical subtypes of NMOSD
por: Yan, Yaping, et al.
Publicado: (2016)

Impaired Meningeal Lymphatic Flow in NMOSD Patients With Acute Attack
por: Wang, Xinxin, et al.
Publicado: (2021)

Enlarged perivascular spaces, neuroinflammation and neurological dysfunction in NMOSD patients
por: Yao, Xiao-Ying, et al.
Publicado: (2022)

The patient journey with NMOSD: From initial diagnosis to chronic condition
por: Delgado-Garcia, Guillermo, et al.
Publicado: (2022)

Rituximab as a first-line preventive treatment in pediatric NMOSDs: Preliminary results in 5 children
por: Longoni, Giulia, et al.
Publicado: (2014)

Multiple sclerosis in First Nations Canadians: A pilot comparison study
por: Marrie, Ruth Ann, et al.
Publicado: (2016)

Failure of alemtuzumab as a rescue in a NMOSD patient treated with rituximab
por: Kowarik, Markus C., et al.
Publicado: (2016)

Paroxysmal sneezing in NMOSD: Further evidence of the localization of the human sneeze center
por: López-Chiriboga, A. Sebastian, et al.
Publicado: (2016)

Microstructural visual system changes in AQP4-antibody–seropositive NMOSD
por: Oertel, Frederike C., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_t05uaid76m1ike9tsuusk258g7